Related Experiment Video
Updated: Jul 20, 2026

MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as a Novel Detection and Quantification Method
Published on: October 7, 2025
MicroRNAs 143 and 145 are possible common onco-microRNAs in human cancers
Yukihiro Akao1, Yoshihito Nakagawa, Tomoki Naoe
1Gifu International Institute of Biotechnology, Gifu 504-0838, Japan. yakao@giib.or.jp
Abstract:
MicroRNAs (miRNAs) are endogenously expressed RNAs 18-24 nucleotides in length that regulate gene expression through translational repression by binding to a target mRNA. It is thought that the expression level of miRNAs, which act like antioncogenes, is frequently reduced in cancers because of chromosome deletion and epigenetic changes. Since the processing of miRNAs has been characterized to be enzymatic in nature, the expression levels of miRNAs are closely associated with the activity and levels of such enzymes. Here, we found that miRNA 143 and 145 expression levels were extremely reduced in colon cancer cells and commonly in the other kinds of cancer cells tested. The transfection of each precursor miRNA into the cells demonstrated a significant growth inhibition in human colon cancer DLD-1 and SW480 cells, and ERK5 was determined to be the target gene of miRNA 143. Since the presence of genomic loci of the miRNAs was confirmed by PCR in the cell lines and the precursor miRNAs exhibited a growth inhibitory effect in DLD-1 and SW480 cells, the early processes such as transcription and enzymatic modification from primary miRNAs to precursor miRNAs seemed to be commonly disturbed. These findings indicate that the miRNAs 143 and 145 could become good tumor markers and provide an important clue in the study of the mechanism of oncogenesis involving miRNAs.
Insights
MicroRNA (miRNA) 143 and 145 levels are significantly reduced in colon cancer cells, suggesting their potential as tumor markers. Restoring these microRNAs inhibited cancer cell growth, highlighting their role in oncogenesis.
Area of Science:
- Molecular Biology
- Oncology
- Genetics
Background:
- MicroRNAs (miRNAs) are small non-coding RNAs regulating gene expression post-transcriptionally.
- Reduced miRNA expression is observed in various cancers, potentially due to genomic alterations and epigenetic modifications.
- Enzymatic processing is crucial for miRNA maturation, linking enzyme activity to miRNA levels.
Purpose of the Study:
- To investigate the expression levels of miRNA 143 and 145 in colon cancer.
- To determine the functional role of miRNA 143 and 145 in cancer cell growth.
- To identify potential therapeutic targets and tumor markers related to these miRNAs.
Main Methods:
- Quantitative analysis of miRNA expression in cancer cell lines.
- Transfection of precursor miRNAs into colon cancer cells (DLD-1 and SW480).
- Assessment of cell growth inhibition post-transfection.
- Identification of miRNA target genes using molecular techniques.
Main Results:
- Significantly reduced expression of miRNA 143 and 145 was observed in colon cancer cells and other tested cancer types.
- Transfection with precursor miRNA 143 or 145 suppressed the growth of colon cancer cells.
- ERK5 was identified as a direct target gene of miRNA 143.
- Genomic loci for these miRNAs were confirmed, suggesting defects in early processing stages.
Conclusions:
- miRNA 143 and 145 downregulation is a common event in colon cancer and potentially other malignancies.
- These miRNAs exhibit tumor-suppressive functions, making them potential therapeutic agents.
- miRNA 143 and 145 represent promising biomarkers for cancer diagnosis and prognosis.
Related Concept Videos
MicroRNAs
MicroRNAs
MicroRNAs
lncRNA - Long Non-coding RNAs
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Abnormal Proliferation

